The News

Genes in 8% of population found to raise heart disease risk


19 Sep 2024

The Financial Times covers a new study that has claimed that thousands of heart attacks and strokes could be prevented by incorporating people’s genetic risk into their standard middle-aged health check. Researchers have identified a suite of genetic changes, affecting 1 in 12 Britons, that significantly raise the chance of suffering heart disease.

Visit website

Genomics plc identifies increased levels of undetected risk of heart disease in UK population


18 Sep 2024

Research by Genomics plc has identified that 8% of the adult population have the same risk of heart disease due to polygenic risk, as carriers of rare genetic mutations that cause familial hypercholesterolemia (FH).

Read article

Why health systems are buying into genomics


17 Sep 2024

Mount Sinai Health System is launching a center that will conduct genetic-based research on undiagnosed medical conditions. The system's Center for Undiagnosed Diseases will open early next year, the latest evidence of the money providers are pouring into genomics. Mount Sinai said Tuesday the center will be home to New York City's first undiagnosed disease network, which connects clinicians across the U.S. conducting this kind of research.

Visit website

Genetic Risk Testing - Policyholder Misconceptions and Benefits to Insurers


15 Aug 2024

As the conversation around genetic risk testing continues to evolve, it's crucial to address the misconceptions that surround it. This latest article by Genomics' Co-Founder and CEO, Sir Peter Donnelly, discusses the common misunderstandings around genetic risk testing and the untapped benefits it holds for the insurance industry.

Visit website

Genomics Announces New Extension and Expansion of Drug Discovery Collaboration with Vertex


17 Jul 2024

The three-year extension expands the range of therapeutic areas and genomic data insights and also explores the use of genomic risk to better define patient subgroups

Read article

Adding genetics to health checks improves identification of people at risk for CVD


12 Jun 2024

We are proud to unveil new findings about our Integrated Risk Tool for cardiovascular disease, which has just achieved another significant validation. A recent study led by the University of Leicester, published in the esteemed European Heart Journal, underscores the transformative potential of our tool in early prevention.

Visit website

Genomics and GSK establish precision medicine collaboration to assess polygenic risk scores in clinical trial design


30 Apr 2024

The collaboration, across multiple therapeutic areas, will evaluate how polygenic risk scores could be used to improve clinical trial design and efficiency

Read article

Genomics and MassMutual's program enables understanding health risks through genetic testing


9 Apr 2024

The wellness offering utilizes advanced genetics to provide personalized risk information for common and preventable diseases, including heart disease, diabetes, breast and prostate cancer

Read article

Genomics plc publishes results of NHS trial in European Journal of Preventive Cardiology


1 Feb 2024

We are delighted to share exciting news in cardiovascular prevention! Genomics plc's study in the European Journal of Preventive Cardiology integrates genetic risk factors for advanced heart disease prediction with QRISK®2. This HEART Study demonstrates that Integrated Risk Tools (IRTs) are a potent combination outperforming existing tools.

Read article

Genomics raises £35 million for advanced genetic testing


8 Jan 2024

An article in The Financial Times by Hannah Kuchler announced the news of the Oxford university spinout's successful fundraise to help predict disease leveraging polygenic risk scores.

Visit website

Genes in 8% of population found to raise heart disease risk


19 Sep 2024

The Financial Times covers a new study that has claimed that thousands of heart attacks and strokes could be prevented by incorporating people’s genetic risk into their standard middle-aged health check. Researchers have identified a suite of genetic changes, affecting 1 in 12 Britons, that significantly raise the chance of suffering heart disease.

Genomics plc identifies increased levels of undetected risk of heart disease in UK population


18 Sep 2024

Research by Genomics plc has identified that 8% of the adult population have the same risk of heart disease due to polygenic risk, as carriers of rare genetic mutations that cause familial hypercholesterolemia (FH).

Why health systems are buying into genomics


17 Sep 2024

Mount Sinai Health System is launching a center that will conduct genetic-based research on undiagnosed medical conditions. The system's Center for Undiagnosed Diseases will open early next year, the latest evidence of the money providers are pouring into genomics. Mount Sinai said Tuesday the center will be home to New York City's first undiagnosed disease network, which connects clinicians across the U.S. conducting this kind of research.

Genetic Risk Testing - Policyholder Misconceptions and Benefits to Insurers


15 Aug 2024

As the conversation around genetic risk testing continues to evolve, it's crucial to address the misconceptions that surround it. This latest article by Genomics' Co-Founder and CEO, Sir Peter Donnelly, discusses the common misunderstandings around genetic risk testing and the untapped benefits it holds for the insurance industry.

Genomics Announces New Extension and Expansion of Drug Discovery Collaboration with Vertex


17 Jul 2024

The three-year extension expands the range of therapeutic areas and genomic data insights and also explores the use of genomic risk to better define patient subgroups

Adding genetics to health checks improves identification of people at risk for CVD


12 Jun 2024

We are proud to unveil new findings about our Integrated Risk Tool for cardiovascular disease, which has just achieved another significant validation. A recent study led by the University of Leicester, published in the esteemed European Heart Journal, underscores the transformative potential of our tool in early prevention.

Genomics and GSK establish precision medicine collaboration to assess polygenic risk scores in clinical trial design


30 Apr 2024

The collaboration, across multiple therapeutic areas, will evaluate how polygenic risk scores could be used to improve clinical trial design and efficiency

Genomics and MassMutual's program enables understanding health risks through genetic testing


9 Apr 2024

The wellness offering utilizes advanced genetics to provide personalized risk information for common and preventable diseases, including heart disease, diabetes, breast and prostate cancer

Genomics plc publishes results of NHS trial in European Journal of Preventive Cardiology


1 Feb 2024

We are delighted to share exciting news in cardiovascular prevention! Genomics plc's study in the European Journal of Preventive Cardiology integrates genetic risk factors for advanced heart disease prediction with QRISK®2. This HEART Study demonstrates that Integrated Risk Tools (IRTs) are a potent combination outperforming existing tools.

Genomics raises £35 million for advanced genetic testing


8 Jan 2024

An article in The Financial Times by Hannah Kuchler announced the news of the Oxford university spinout's successful fundraise to help predict disease leveraging polygenic risk scores.

Genes in 8% of population found to raise heart disease risk


19 Sep 2024

The Financial Times covers a new study that has claimed that thousands of heart attacks and strokes could be prevented by incorporating people’s genetic risk into their standard middle-aged health check. Researchers have identified a suite of genetic changes, affecting 1 in 12 Britons, that significantly raise the chance of suffering heart disease.

Genomics plc identifies increased levels of undetected risk of heart disease in UK population


18 Sep 2024

Research by Genomics plc has identified that 8% of the adult population have the same risk of heart disease due to polygenic risk, as carriers of rare genetic mutations that cause familial hypercholesterolemia (FH).

Why health systems are buying into genomics


17 Sep 2024

Mount Sinai Health System is launching a center that will conduct genetic-based research on undiagnosed medical conditions. The system's Center for Undiagnosed Diseases will open early next year, the latest evidence of the money providers are pouring into genomics. Mount Sinai said Tuesday the center will be home to New York City's first undiagnosed disease network, which connects clinicians across the U.S. conducting this kind of research.

Genetic Risk Testing - Policyholder Misconceptions and Benefits to Insurers


15 Aug 2024

As the conversation around genetic risk testing continues to evolve, it's crucial to address the misconceptions that surround it. This latest article by Genomics' Co-Founder and CEO, Sir Peter Donnelly, discusses the common misunderstandings around genetic risk testing and the untapped benefits it holds for the insurance industry.

Genomics Announces New Extension and Expansion of Drug Discovery Collaboration with Vertex


17 Jul 2024

The three-year extension expands the range of therapeutic areas and genomic data insights and also explores the use of genomic risk to better define patient subgroups

Adding genetics to health checks improves identification of people at risk for CVD


12 Jun 2024

We are proud to unveil new findings about our Integrated Risk Tool for cardiovascular disease, which has just achieved another significant validation. A recent study led by the University of Leicester, published in the esteemed European Heart Journal, underscores the transformative potential of our tool in early prevention.

Genomics and GSK establish precision medicine collaboration to assess polygenic risk scores in clinical trial design


30 Apr 2024

The collaboration, across multiple therapeutic areas, will evaluate how polygenic risk scores could be used to improve clinical trial design and efficiency

Genomics and MassMutual's program enables understanding health risks through genetic testing


9 Apr 2024

The wellness offering utilizes advanced genetics to provide personalized risk information for common and preventable diseases, including heart disease, diabetes, breast and prostate cancer

Genomics plc publishes results of NHS trial in European Journal of Preventive Cardiology


1 Feb 2024

We are delighted to share exciting news in cardiovascular prevention! Genomics plc's study in the European Journal of Preventive Cardiology integrates genetic risk factors for advanced heart disease prediction with QRISK®2. This HEART Study demonstrates that Integrated Risk Tools (IRTs) are a potent combination outperforming existing tools.

Genomics raises £35 million for advanced genetic testing


8 Jan 2024

An article in The Financial Times by Hannah Kuchler announced the news of the Oxford university spinout's successful fundraise to help predict disease leveraging polygenic risk scores.

Genes in 8% of population found to raise heart disease risk


19 Sep 2024

The Financial Times covers a new study that has claimed that thousands of heart attacks and strokes could be prevented by incorporating people’s genetic risk into their standard middle-aged health check. Researchers have identified a suite of genetic changes, affecting 1 in 12 Britons, that significantly raise the chance of suffering heart disease.

Visit website

Genomics plc identifies increased levels of undetected risk of heart disease in UK population


18 Sep 2024

Research by Genomics plc has identified that 8% of the adult population have the same risk of heart disease due to polygenic risk, as carriers of rare genetic mutations that cause familial hypercholesterolemia (FH).

Read article

Why health systems are buying into genomics


17 Sep 2024

Mount Sinai Health System is launching a center that will conduct genetic-based research on undiagnosed medical conditions. The system's Center for Undiagnosed Diseases will open early next year, the latest evidence of the money providers are pouring into genomics. Mount Sinai said Tuesday the center will be home to New York City's first undiagnosed disease network, which connects clinicians across the U.S. conducting this kind of research.

Visit website

Genetic Risk Testing - Policyholder Misconceptions and Benefits to Insurers


15 Aug 2024

As the conversation around genetic risk testing continues to evolve, it's crucial to address the misconceptions that surround it. This latest article by Genomics' Co-Founder and CEO, Sir Peter Donnelly, discusses the common misunderstandings around genetic risk testing and the untapped benefits it holds for the insurance industry.

Visit website

Genomics Announces New Extension and Expansion of Drug Discovery Collaboration with Vertex


17 Jul 2024

The three-year extension expands the range of therapeutic areas and genomic data insights and also explores the use of genomic risk to better define patient subgroups

Read article

Adding genetics to health checks improves identification of people at risk for CVD


12 Jun 2024

We are proud to unveil new findings about our Integrated Risk Tool for cardiovascular disease, which has just achieved another significant validation. A recent study led by the University of Leicester, published in the esteemed European Heart Journal, underscores the transformative potential of our tool in early prevention.

Visit website

Genomics and GSK establish precision medicine collaboration to assess polygenic risk scores in clinical trial design


30 Apr 2024

The collaboration, across multiple therapeutic areas, will evaluate how polygenic risk scores could be used to improve clinical trial design and efficiency

Read article

Genomics and MassMutual's program enables understanding health risks through genetic testing


9 Apr 2024

The wellness offering utilizes advanced genetics to provide personalized risk information for common and preventable diseases, including heart disease, diabetes, breast and prostate cancer

Read article

Genomics plc publishes results of NHS trial in European Journal of Preventive Cardiology


1 Feb 2024

We are delighted to share exciting news in cardiovascular prevention! Genomics plc's study in the European Journal of Preventive Cardiology integrates genetic risk factors for advanced heart disease prediction with QRISK®2. This HEART Study demonstrates that Integrated Risk Tools (IRTs) are a potent combination outperforming existing tools.

Read article

Genomics raises £35 million for advanced genetic testing


8 Jan 2024

An article in The Financial Times by Hannah Kuchler announced the news of the Oxford university spinout's successful fundraise to help predict disease leveraging polygenic risk scores.

Visit website